title: An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients.
authors.forename: P
authors.initials: P
authors.lastname: Ferroni
authors.forename: F
authors.initials: F
authors.lastname: Martini
authors.forename: I
authors.initials: I
authors.lastname: Portarena
authors.forename: I
authors.initials: I
authors.lastname: Grenga
authors.forename: S
authors.initials: S
authors.lastname: Riondino
authors.forename: F
authors.initials: F
authors.lastname: La Farina
authors.forename: A
authors.initials: A
authors.lastname: Laudisi
authors.forename: M
authors.initials: M
authors.lastname: Roselli
authors.forename: F
authors.initials: F
authors.lastname: Guadagni
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001780:Blood Coagulation Tests; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D011237:Predictive Value of Tests; D011486:Protein C / Q000378:metabolism; D012680:Sensitivity and Specificity; D013917:Thrombin / Q000378:metabolism*; D054556:Venous Thromboembolism / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D011486:Protein C; D013917:Thrombin